To finely dissect the relationship between quantitative methylation and the clinical outcomes as well as the biological precursor phenotypes expressed in MetS, we examined our extensively phenotyped cohort and identified several CpG sites that were associated with lipids, insulin and blood pressure measures. This evidence concerns the gene INS and metabolic syndrome.